表紙
市場調查報告書

肽治療藥市場:全球趨勢與預測

Peptide Therapeutics Market - Global Forecast to 2026

出版商 Coherent Market Insights 商品編碼 664200
出版日期 內容資訊 英文 189 Pages
商品交期: 2-3個工作天內
價格
Back to Top
肽治療藥市場:全球趨勢與預測 Peptide Therapeutics Market - Global Forecast to 2026
出版日期: 2018年06月21日內容資訊: 英文 189 Pages
簡介

本報告提供全球肽治療藥市場相關調查,彙整市場現狀與成長預測,各類型,各用途,給藥途徑,各地區趨勢,及加入此市場的主要企業的簡介等資料。

第1章 調查目的與假設

第2章 市場概要

第3章 市場趨勢,法律規章,趨勢分析

  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
  • 法律規章方案
  • 市場趨勢
  • 流行病學
  • 合併·收購
  • 新產品的認證/上市
  • 開發平台分析
  • PEST分析

第4章 各類型市場

  • 簡介
  • 品牌藥
  • 學名藥

第5章 各用途市場

  • 簡介
  • 癌症
  • 心血管疾病
  • 代謝性疾病
  • 呼吸疾病
  • 感染疾病
  • 其他

第6章 各給藥途徑市場

  • 簡介
  • 口服給藥
  • 非口服給藥
  • 其他

第7章 各地區市場

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 非洲
  • 中東

第8章 競爭環境

  • 熱圖分析
  • 企業簡介
  • 企業概要
  • 技術組合
  • 財務趨勢
  • 近幾年的發展/更新

第9章 章節

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Report Description

  • Peptide therapeutics continue to expands its application by broaden molecular diversity and by engineering enhanced pharmaceutical properties. Research continues to expand the potential range of peptide-based pharmaceuticals to focus on treatment targets. However, large number of peptide targets shown in its early-stage of clinical trials or in preclinical models of disease, such as a melanocortin 4 receptor (MC4R) agonist, may reduce the body weight of patients with genetic obesity syndromes.
  • Furthermore, increasing development are in progress to extend the half-life period of peptide drugs; to improve the oral bioavailability of peptide therapeutics and to enhance the Central Nervous System (CNS) availability of peptide drugs through nanoparticle delivery in the indications such as Alzheimer's disease and stroke.

Market Dynamics

  • Market players are engaged in developing novel and innovative peptide therapeutics drugs in order to offer tailored solution to target patient by increasing biocompatibility and potent therapeutic effects. Increasing prevalence of cancer and diabetes mellitus is projected to drive growth of the peptide therapeutics market over the forecast period. Also, clinical development in the field of peptide reflects it as an effective tool for molecular pharmacology.

Key features of the study:

  • This report provides in-depth analysis of peptide therapeutics in medical sector and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global peptide therapeutics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Takeda Pharmaceuticals Co. Ltd., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Encycle Therapeutics, Inc., CirclePharma, Inc., Pfizer Inc., Novartis AG, PeptiDream Inc., Amgen Inc., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics
  • The global peptide therapeutics market report caters to various stakeholders in this industry including investors, suppliers, peptide therapeutics based product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the peptide therapeutics market.

Detailed Segmentation:

  • Global Peptide Therapeutics Market, By Type:
  • Branded Peptide
  • Generic Peptide
  • Global Peptide Therapeutics Market, By Application:
  • Cancer
  • Cardiovascular Disease
  • Metabolic Disease
  • Respiratory Disease
  • Infectious Disease
  • Others
  • Global Peptide Therapeutics Market, By Route of Administration:
  • Oral Administration
  • Parenteral Administration
  • Others
  • Global Peptide Therapeutics Market, By Geography:
  • North America
    • By Country:
  • U.S.
  • Canada
    • By Type:
  • Branded Peptide
  • Generic Peptide
    • By Application
  • Cancer
  • Cardiovascular Disease
  • Metabolic Disease
  • Respiratory Disease
  • Infectious Disease
  • Others
    • By Route of Administration:
  • Oral Administration
  • Parenteral Administration
  • Others
  • Europe
    • By Country:
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Russia
  • Rest of Europe
    • By Type:
  • Branded Peptide
  • Generic Peptide
    • By Application
  • Cancer
  • Cardiovascular Disease
  • Metabolic Disease
  • Respiratory Disease
  • Infectious Disease
  • Others
    • By Route of Administration:
  • Oral Administration
  • Parenteral Administration
  • Others
  • Asia Pacific
    • By Country:
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific
    • By Type:
  • Branded Peptide
  • Generic Peptide
    • By Application
  • Cancer
  • Cardiovascular Disease
  • Metabolic Disease
  • Respiratory Disease
  • Infectious Disease
  • Others
    • By Route of Administration:
  • Oral Administration
  • Parenteral Administration
  • Others
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
    • By Type:
  • Branded Peptide
  • Generic Peptide
    • By Application
  • Cancer
  • Cardiovascular Disease
  • Metabolic Disease
  • Respiratory Disease
  • Infectious Disease
  • Others
    • By Route of Administration:
  • Oral Administration
  • Parenteral Administration
  • Others
  • Latin America
    • By Country:
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
    • By Type:
  • Branded Peptide
  • Generic Peptide
    • By Application
  • Cancer
  • Cardiovascular Disease
  • Metabolic Disease
  • Respiratory Disease
  • Infectious Disease
  • Others
    • By Route of Administration:
  • Oral Administration
  • Parenteral Administration
  • Others
  • Africa
    • By Country:
  • South Africa
  • Central Africa
  • North Africa
    • By Type:
  • Branded Peptide
  • Generic Peptide
    • By Application
  • Cancer
  • Cardiovascular Disease
  • Metabolic Disease
  • Respiratory Disease
  • Infectious Disease
  • Others
    • By Route of Administration:
  • Oral Administration
  • Parenteral Administration
  • Others
  • Company Profiles
  • Teva Pharmaceutical Industries Ltd.*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments
    • Strategies
  • Takeda Pharmaceuticals Co. Ltd.
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi S.A.
  • Encycle Therapeutics, Inc.
  • CirclePharma, Inc.
  • Pfizer Inc.
  • Novartis AG
  • PeptiDream Inc.
  • Amgen Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet By Type
    • Market Snippet By Application
    • Market Snippet By Route of Administration
    • Market Snippet By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Regulatory Scenario
  • Market Trends
  • Epidemiology
  • Merger and Acquisitions
  • New Product Approvals/Launch
  • Pipeline Analysis
  • PEST Analysis

4. Global Peptide Therapeutics Market, By Type, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-O-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Branded Peptide
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Generic Peptide
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)

5. Global Peptide Therapeutics Market, By Application, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-O-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Cancer
    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-O-Y Growth Analysis, 2017 - 2026
  • Cardiovascular Disease
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Metabolic Disease
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Respiratory Disease
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Infectious Disease
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)

6. Global Peptide Therapeutics Market, By Route of Administration, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-O-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Oral Administration
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Parenteral Administration
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)

7. Global Peptide Therapeutics Market, By Regions, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-O-Y Growth Analysis, For Regions, 2017 - 2026
  • North America
    • Market Size and Forecast, By Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • U.S.
  • Canada
  • Europe
    • Market Size and Forecast, By Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • Northern Africa
  • Central Africa
  • South Africa
  • Middle East
    • Market Size and Forecast, By Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • GCC Countries
  • Israel
  • Rest of Middle East

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Technology Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Takeda Pharmaceuticals Co. Ltd.
  • Company Overview
  • Technology Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Novo Nordisk A/S
  • Company Overview
  • Technology Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Eli Lilly and Company
  • Company Overview
  • Technology Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Sanofi S.A.
  • Company Overview
  • Technology Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Encycle Therapeutics, Inc.
  • Company Overview
  • Technology Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • CirclePharma, Inc.
  • Company Overview
  • Technology Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Pfizer Inc.
  • Company Overview
  • Technology Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Novartis AG
  • Company Overview
  • Technology Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • PeptiDream Inc.
  • Company Overview
  • Technology Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Amgen Inc.
  • Company Overview
  • Technology Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Analyst Views

9. Section

  • References
  • Analyst Views
  • Research Methodology
  • About Us and Sales Contact
Back to Top